| SOXS 1.825 1.96% | TPET 1.0884 159.14% | ONDS 10.375 2.93% | STAK 0.9083 113.72% | NVDA 182.125 2.79% | BITO 9.51 4.97% | TMDE 2.5991 181.84% | XLE 56.975 1.89% | TZA 6.085 -2.33% | NVD 7.105 -5.64% | DUST 3.615 2.12% | NOK 8.245 6.80% | TURB 1.2801 89.53% | TQQQ 49.4125 -0.22% | RYDE 0.3659 58.12% | F 13.345 -5.29% | IBIT 39.1438 5.25% | EONR 0.5219 20.81% | PLUG 1.81 1.12% | MSTX 2.52 12.00% | BHAT 0.0379 -23.43% | SLV 81.2999 -4.34% | TSLS 5.675 0.62% | USEG 1.2197 13.99% | AAL 12.505 -4.32% | SOXL 61.83 -1.50% | BATL 13.1467 138.16% | AES 14.295 -17.27% | JDST 1.1999 3.44% | SPY 685.645 -0.05% | QQQ 606.928 -0.06% | HYG 80.325 -0.49% | SQQQ 70.99 0.20% | PLTR 144.46 5.30% | NFLX 97.41 1.22% | MARA 9.575 7.10% | SOFI 17.9768 1.22% | TSLL 14.49 -1.43% | ETHA 15.385 5.96% | NU 15.22 1.60% | XLF 51.365 -0.13% | INTC 45.2088 -0.88% | IWM 263.43 0.77% | TSLA 399.5588 -0.73% | NIO 4.695 -3.59% | RIG 6.24 -3.70% | TLT 89.535 -1.41% | BMNR 20.39 7.43% | TSDD 9.315 1.47% | BKLN 20.22 0.05%

Taylor Morrison Home Corporation (NYSE: TMHC) Surpasses Earnings and Revenue Estimates

Taylor Morrison Home Corporation (NYSE:TMHC) is a leading national land developer and homebuilder, known for its strategic management of inventory, pricing, and sales pace across its communities. Operating in the Zacks Building Products - Home Builders industry, TMHC has consistently outperformed revenue estimates over the past four quarters.

On October 22, 2025, TMHC reported earnings per share (EPS) of $2.01, surpassing the estimated $1.93. This achievement highlights the company's ability to exceed Wall Street expectations. Despite a year-over-year decline in EPS from $2.37, TMHC still delivered a positive surprise of 9.33%, as highlighted by Zacks.

TMHC's revenue for the third quarter of 2025 was $2.1 billion, slightly lower than the previous year's $2.12 billion. However, this figure exceeded the Zacks Consensus Estimate of $2.04 billion, resulting in a positive surprise of 2.76%. This performance underscores the company's resilience in challenging market conditions.

The company's financial health is further supported by a price-to-earnings (P/E) ratio of approximately 6.86, indicating a relatively low valuation compared to its earnings. TMHC's price-to-sales ratio of about 0.73 suggests the market values the company at less than its annual sales, while the enterprise value to sales ratio is approximately 0.97.

TMHC maintains a strong current ratio of approximately 9.43, reflecting its robust ability to cover short-term liabilities with short-term assets. The debt-to-equity ratio of about 0.36 shows a moderate level of debt compared to equity, indicating a balanced financial structure.

Published on: October 22, 2025